12:00 AM
Mar 12, 2012
 |  BC Week In Review  |  Company News  |  Other News

GlaxoSmithKline, The Wellcome Trust, University of Dundee infectious news

The university and GlaxoSmithKline received £8.6 million ($13.6 million) from the Wellcome Trust to develop treatments for Chagas disease, leishmaniasis...

Read the full 78 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >